Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 Aug;34(8):1075–1080. doi: 10.1136/gut.34.8.1075

Failure of colonoscopic surveillance in ulcerative colitis.

D A Lynch 1, A J Lobo 1, G M Sobala 1, M F Dixon 1, A T Axon 1
PMCID: PMC1374357  PMID: 8174957

Abstract

A prospective surveillance programme for patients with longstanding (> = 8 years), extensive (> = splenic flexure) ulcerative colitis was undertaken between 1978 and 1990. It comprised annual colonoscopy with pancolonic biopsy. One hundred and sixty patients were entered into the programme and had 739 colonoscopies (4.6 colonoscopies per patient; 709 patient years follow up). Eight eight per cent of examinations reached the right colon. There was no procedure related death. One Dukes's A cancer was detected. Forty one patients (25%) defaulted. Of these 25 remain well; 13 are unaccounted for, and one died from colonic cancer. One patient had colectomy for medical reasons, and another died of carcinoma of the pancreas. Retrospectively an additional 16 eligible patients were identified who had not been recruited. Of these, 14 remain well, two are unaccounted for. None developed colonic cancer. Four patients refused colonoscopy. All remain well. Over the same period seven other cases of colonic cancer were found in association with ulcerative colitis, two in patients who had erroneously been diagnosed as having only proctitis and were therefore not entered into the programme, but were found at operation to have total colitis, one in a patient with colitis of seven years duration, and four patients who had previously attended the clinic but had been lost to follow up before 1978 and then had represented with new symptoms during the surveillance period. Thus, of the nine colitis related cancers diagnosed in this centre during the study period only one was detected by the surveillance programme. The results of this large study, a a review of published works, cast doubts on the effectiveness of colonoscopic surveillance programmes in detecting colorectal cancer in patients with ulcerative colitis.

Full text

PDF
1075

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackstone M. O., Riddell R. H., Rogers B. H., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981 Feb;80(2):366–374. [PubMed] [Google Scholar]
  2. Broström O., Löfberg R., Ost A., Reichard H. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut. 1986 Dec;27(12):1408–1413. doi: 10.1136/gut.27.12.1408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collins R. H., Jr, Feldman M., Fordtran J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987 Jun 25;316(26):1654–1658. doi: 10.1056/NEJM198706253162609. [DOI] [PubMed] [Google Scholar]
  4. Cook M. G., Goligher J. C. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology. 1975 May;68(5 Pt 1):1127–1136. [PubMed] [Google Scholar]
  5. Cuvelier C. A., Morson B. C., Roels H. J. The DNA content in cancer and dysplasia in chronic ulcerative colitis. Histopathology. 1987 Sep;11(9):927–939. doi: 10.1111/j.1365-2559.1987.tb01899.x. [DOI] [PubMed] [Google Scholar]
  6. De Dombal F. T., Watts J. M., Watkinson G., Goligher J. C. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J. 1966 Jun 11;1(5501):1442–1447. doi: 10.1136/bmj.1.5501.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Devroede G. J., Taylor W. F., Sauer W. G., Jackman R. J., Stickler G. B. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med. 1971 Jul 1;285(1):17–21. doi: 10.1056/NEJM197107012850103. [DOI] [PubMed] [Google Scholar]
  8. Dickinson R. J., Dixon M. F., Axon A. T. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet. 1980 Sep 20;2(8195 Pt 1):620–622. doi: 10.1016/s0140-6736(80)90286-x. [DOI] [PubMed] [Google Scholar]
  9. Dixon M. F., Brown L. J., Gilmour H. M., Price A. B., Smeeton N. C., Talbot I. C., Williams G. T. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology. 1988 Oct;13(4):385–397. doi: 10.1111/j.1365-2559.1988.tb02055.x. [DOI] [PubMed] [Google Scholar]
  10. Fozard J. B., Dixon M. F., Axon A. T., Giles G. R. Lectin and mucin histochemistry as an aid to cancer surveillance in ulcerative colitis. Histopathology. 1987 Apr;11(4):385–394. doi: 10.1111/j.1365-2559.1987.tb02643.x. [DOI] [PubMed] [Google Scholar]
  11. Fuson J. A., Farmer R. G., Hawk A., Sullivan B. H. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol. 1980 Feb;73(2):120–126. [PubMed] [Google Scholar]
  12. Gyde S. N., Prior P., Allan R. N., Stevens A., Jewell D. P., Truelove S. C., Lofberg R., Brostrom O., Hellers G. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988 Feb;29(2):206–217. doi: 10.1136/gut.29.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut. 1990 Oct;31(10):1089–1092. doi: 10.1136/gut.31.10.1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jones H. W., Grogono J., Hoare A. M. Surveillance in ulcerative colitis: burdens and benefit. Gut. 1988 Mar;29(3):325–331. doi: 10.1136/gut.29.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kewenter J., Ahlman H., Hultén L. Cancer risk in extensive ulcerative colitis. Ann Surg. 1978 Dec;188(6):824–828. doi: 10.1097/00000658-197812000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lashner B. A., Kane S. V., Hanauer S. B. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol. 1990 Sep;85(9):1083–1087. [PubMed] [Google Scholar]
  17. Lashner B. A., Silverstein M. D., Hanauer S. B. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci. 1989 Oct;34(10):1536–1541. doi: 10.1007/BF01537106. [DOI] [PubMed] [Google Scholar]
  18. Leidenius M., Kellokumpu I., Husa A., Riihelä M., Sipponen P. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut. 1991 Dec;32(12):1521–1525. doi: 10.1136/gut.32.12.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lennard-Jones J. E. Compliance, cost, and common sense limit cancer control in colitis. Gut. 1986 Dec;27(12):1403–1407. doi: 10.1136/gut.27.12.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lennard-Jones J. E., Melville D. M., Morson B. C., Ritchie J. K., Williams C. B. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990 Jul;31(7):800–806. doi: 10.1136/gut.31.7.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Shove D. C., Williams C. B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology. 1977 Dec;73(6):1280–1289. [PubMed] [Google Scholar]
  22. Lennard-Jones J. E., Morson B. C., Ritchie J. K., Williams C. B. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet. 1983 Jul 16;2(8342):149–152. doi: 10.1016/s0140-6736(83)90129-0. [DOI] [PubMed] [Google Scholar]
  23. Löfberg R., Broström O., Karlén P., Tribukait B., Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology. 1990 Oct;99(4):1021–1031. doi: 10.1016/0016-5085(90)90622-8. [DOI] [PubMed] [Google Scholar]
  24. MACDOUGALL I. P. THE CANCER RISK IN ULCERATIVE COLITIS. Lancet. 1964 Sep 26;2(7361):655–658. doi: 10.1016/s0140-6736(64)92474-2. [DOI] [PubMed] [Google Scholar]
  25. Manning A. P., Bulgim O. R., Dixon M. F., Axon A. T. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut. 1987 Nov;28(11):1489–1494. doi: 10.1136/gut.28.11.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Melville D. M., Jass J. R., Shepherd N. A., Northover J. M., Capellaro D., Richman P. I., Lennard-Jones J. E., Ritchie J. K., Andersen S. N. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations. Gastroenterology. 1988 Sep;95(3):668–675. doi: 10.1016/s0016-5085(88)80013-1. [DOI] [PubMed] [Google Scholar]
  27. Morson B. C., Pang L. S. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut. 1967 Oct;8(5):423–434. doi: 10.1136/gut.8.5.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Morson B. C. Precancer and cancer in inflammatory bowel disease. Pathology. 1985 Apr;17(2):173–180. doi: 10.3109/00313028509063753. [DOI] [PubMed] [Google Scholar]
  29. Nugent F. W., Haggitt R. C., Gilpin P. A. Cancer surveillance in ulcerative colitis. Gastroenterology. 1991 May;100(5 Pt 1):1241–1248. [PubMed] [Google Scholar]
  30. Rex D. K., Lehman G. A., Hawes R. H., Ulbright T. M., Smith J. J. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology. 1991 Jan;100(1):64–67. doi: 10.1016/0016-5085(91)90583-7. [DOI] [PubMed] [Google Scholar]
  31. Riddell R. H. The precarcinomatous phase of ulcerative colitis. Curr Top Pathol. 1976;63:179–219. doi: 10.1007/978-3-642-66481-6_6. [DOI] [PubMed] [Google Scholar]
  32. Rosenstock E., Farmer R. G., Petras R., Sivak M. V., Jr, Rankin G. B., Sullivan B. H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology. 1985 Dec;89(6):1342–1346. doi: 10.1016/0016-5085(85)90653-5. [DOI] [PubMed] [Google Scholar]
  33. Rutegård J., Ahsgren L., Stenling R., Janunger K. G. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol. 1988 Mar;23(2):139–145. doi: 10.3109/00365528809103958. [DOI] [PubMed] [Google Scholar]
  34. Weil J., Langman M. J. Screening for gastrointestinal cancer: an epidemiological review. Gut. 1991 Feb;32(2):220–224. doi: 10.1136/gut.32.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Woolrich A. J., DaSilva M. D., Korelitz B. I. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1992 Aug;103(2):431–438. doi: 10.1016/0016-5085(92)90831-i. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES